Morningstar’s Dave Sekera shares his top value stock picks
Dave Sekera, Morningstar's Chief U.S. Market Strategist says the best value is in the small cap category. Source link
Read more Morningstar’s Dave Sekera shares his top value stock picksTag: Bristol-Myers Squibb Co
Judge rejects J&J, Bristol Myers Squibb challenges to Medicare drug-price negotiations
Jonathan Raa | Nurphoto | Getty Images A federal judge in New Jersey on Monday rejected Johnson & Johnson‘s and Bristol Myers Squibb‘s legal challenges to the Biden…
Read more Judge rejects J&J, Bristol Myers Squibb challenges to Medicare drug-price negotiations
Cramer's week ahead: Earnings season kicks off after JPMorgan Healthcare Conference
CNBC’s Jim Cramer on Friday told investors what to watch for on Wall Street next week, highlighting JPMorgan‘s market-moving health-care conference in San Francisco. Taking place from Monday…
Read more Cramer's week ahead: Earnings season kicks off after JPMorgan Healthcare Conference
Wednesday’s analyst calls: DraftKings bull case, credit card play for the long haul
(This is CNBC Pro’s live coverage of Wednesday’s analyst calls and Wall Street chatter. Please refresh every 20-30 minutes to view the latest posts.) Wednesday’s batch of analyst…
Read more Wednesday’s analyst calls: DraftKings bull case, credit card play for the long haul
5 things to know before the stock market opens Monday
Here are the most important news items that investors need to start their trading day: 1. Bond yield boost U.S. stock futures slid Monday morning as the 10-year…
Read more 5 things to know before the stock market opens Monday
Bristol Myers Squibb to buy Mirati Therapeutics in deal worth up to $5.8 billion
Bristol Myers Squibb Co. said Sunday it will buy Mirati Therapeutics Inc. in a deal valued at up to $5.8 billion. The pharmaceutical giant announced it will pay…
Read more Bristol Myers Squibb to buy Mirati Therapeutics in deal worth up to $5.8 billion
Federal judge declines to block Medicare drug price negotiations
A pharmacist holds a bottle of the drug Eliquis, made by Pfizer Pharmaceuticals, at a pharmacy in Provo, Utah, January 9, 2020. George Frey | Reuters A federal…
Read more Federal judge declines to block Medicare drug price negotiations
Pharmaceutical trade group sues Biden administration over Medicare drug price negotiations
Traders work on the floor of the New York Stock Exchange during morning trading, April 10, 2023. Michael M. Santiago | Getty Images The pharmaceutical industry’s largest lobbying…
Read more Pharmaceutical trade group sues Biden administration over Medicare drug price negotiations
Bristol Myers Squibb sues Biden administration over Medicare drug negotiations in third such lawsuit
Bristol Myers Squibb on Friday sued the Biden administration over Medicare‘s new powers to slash drug prices, the third such lawsuit to be filed against the program in…
Read more Bristol Myers Squibb sues Biden administration over Medicare drug negotiations in third such lawsuit
Analysts love these stocks that are flush with cash — giving one over 75% upside
Investors are preparing for a gloomy 2023 by doubling down on cash-rich companies . “We prefer companies generating cash rather than those that need capital to grow. Not…
Read more Analysts love these stocks that are flush with cash — giving one over 75% upside